Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Giant Cell Arteritis
Swanson, Jerry W., Smith, Jonathan H.

Headache: The Journal of Head and Face Pain | July 18, 2014 | Volume: 54 | Issue: 8 | Pages: 1273-1289

10.1111/head.12425 | PMID 25041449 Get It

Giant cell arteritis ( GCA ) is a medium and large‐vessel vasculitis, which is an important cause of secondary headache in older adults. While GCA has a classic presentation occurring after the age of 50, atypical presentations (eg, fever of unknown origin, cough, low or normal erythrocyte sedimentation rate) may lead to a delay in diagnosis. The topography of vascular involvement has implications for disease‐related complications, which can result in neurologic disease at multiple levels of the nervous system. The most feared complication, vision loss, fortunately becomes uncommon after initiation of corticosteroids. Corticosteroid treatment should not be withheld while waiting the results of a temporal artery biopsy ( TAB ), which remains the gold standard for GCA diagnosis. Newer diagnostic modalities, including ultrasound, magnetic resonance imaging, and positron emission tomography can play an important role in directing treatment in cases with negative TAB . After successful control of the disorder, patients should be gradually tapered off corticosteroids, with careful monitoring using both clinical and laboratory parameters to assess for relapse. Corticosteroid‐related treatment complications are not uncommon in GCA . There is mixed evidence for use of adjunct corticosteroid‐sparing agents (eg, methotrexate), although these should be initiated in the setting of corticosteroid‐related morbidity and/or cases with frequent relapse.
Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high‐risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin‐amphotericin co
Abidi, Maheen Z. , Sohail, M. Rizwan , Wilhelm, Mark , Wengenack, Nancy L. , Brumble, Lisa , Shah, Harshal , Hata, D. Jane , McCullough, Ann E. , Wendel, Amy J., Vikram, Holenarasipur R. , Kusne, Shimon , Litzow, Mark R. , Letendre, Louis, Lahr, Brian D. , Poeschla, Eric M. , Walker, Randall C., Cummins, Nathan W. , Vikram, Holenarasipur R. , Sohail, M Rizwan , Abidi, Maheen Z , Abidi, Maheen Z

Mycoses | July 18, 2014 | Volume: 57 | Issue: 11 | Pages: 687-698

10.1111/myc.12222 | PMID 25040241 Get It

SummaryAs invasive mucormycosis (IM) numbers rise, clinicians suspect prior voriconazole worsens IM incidence and severity, and believe combination anti‐fungal therapy improves IM survival. To compare the cumulative incidence (CI), severity and mortality of IM in eras immediately before and after the commercial availability of voriconazole all IM cases from 1995 to 2011 were analysed across four risk‐groups (hematologic/oncologic malignancy (H/O), stem cell transplantation (SCT), solid organ transplantation (SOT) and other), and two eras, E1 (1995–2003) and E2, (2004–2011). Of 101 IM cases, (79 proven, 22 probable): 30 were in E1 (3.3/year) and 71 in E2 (8.9/year). Between eras, the proportion with H/O or SCT rose from 47% to 73%, while ‘other’ dropped from 33% to 11% (P = 0.036). Between eras, the CI of IM did not significantly increase in SCT (P = 0.27) or SOT (P = 0.30), and patterns of anatomic location (P = 0.122) and surgical debridement (P = 0.200) were similar. Significantly more patients received amphotericin‐echinocandin combination therapy in E2 (31% vs. 5%, P = 0.01); however, 90‐day survival did not improve (54% vs. 59%, P = 0.67). Since 2003, the rise of IM reflects increasing numbers at risk, not prior use of voriconazole. Frequent combination of anti‐fungal therapy has not improved survival.
From prednisone to pylori: a case of Helicobacter pylori-induced chronic immune thrombocytopenia
Hill, Larisa J N, Tung, Ericka E. , Hill, Larisa J.N.

BMJ Case Reports | July 18, 2014 | Volume: 2014 | Issue: No issue available | Pages: bcr2014205786

10.1136/bcr-2014-205786 | PMID 25035453 Get It

A 54-year-old woman was seen by her primary care internist for a general health maintenance visit. Her major chronic illness was immune thrombocytopenic purpura (ITP) for which she had been treated with prednisone therapy for the past 15 years. Recent review of possible aetiologies of her chronic thrombocytopenia revealed infection with Helicobacter pylori. Successful eradication resulted in complete resolution of her thrombocytopenia within 2 months. She was weaned from steroid therapy and at 1-year follow-up, her platelet counts remained in the normal range. This case report summarises what is known about the association of H. pylori infection and ITP.
ACE inhibitors: upper respiratory symptoms
Pinargote, Paulette, Guillen, Denisse E, Guarderas, Juan , Guillen, Denisse, Guarderas, Juan C

BMJ Case Reports | July 18, 2014 | Volume: 2014 | Issue: No issue available | Pages: bcr2014205462

10.1136/bcr-2014-205462 | PMID 25035451 Get It

Cough and angioedema are well-known adverse reactions of ACE inhibitors. However, other adverse effects of upper airways such as postnasal drainage, rhinitis and nasal blockage, are less frequently recognised. These might share the same pathophysiological mechanism: bradykinin accumulation. We present two patients with ACE inhibitor-induced upper respiratory symptoms that improved after the discontinuation of ACE-inhibitors and substitution with angiotensin II receptor blockers. The incidence of these adverse events is not accurately known, since these are not required to be reported, but it is estimated to be low. This presents challenges to the physician and demonstrates the importance of keeping it as a differential diagnosis. Most physicians are aware of ACE inhibitor-induced cough but not of ACE inhibitor-induced nasal blockage, rhinitis or postnasal drainage. Identifying these can avoid unnecessary diagnostic tests and inappropriate treatment.
Acute cyclooxygenase inhibition does not alter muscle sympathetic nerve activity or forearm vasodilator responsiveness in lean and obese adults
Barnes, Jill N. , Charkoudian, Nisha , Matzek, Luke J. , Johnson, Christopher P., Joyner, Michael J. , Curry, Timothy B. , Barnes, J N , Joyner, Michael J

Physiological Reports | July 17, 2014 | Volume: 2 | Issue: 7 | Pages: e12079

10.14814/phy2.12079 | PMID 25347862 Get It

Answer to August 2014 Photo Quiz
Relich, Ryan F. , Faught, Phillip R., McCoy, Morgan H., Alexander, Riley E., Pritt, Bobbi S. , Pritt, Bobbi S

Journal of Clinical Microbiology | July 17, 2014 | Volume: 52 | Issue: 8 | Pages: 3138-3138

10.1128/jcm.00700-13 Get It

Photo Quiz: An Unexpected Colonoscopic Finding in a 13-Year-Old Boy
Relich, Ryan F. , Faught, Phillip R., McCoy, Morgan H., Alexander, Riley E., Pritt, Bobbi S. , Pritt, Bobbi S

Journal of Clinical Microbiology | July 17, 2014 | Volume: 52 | Issue: 8 | Pages: 2749-2749

10.1128/jcm.00699-13 | PMID 25035510 Get It

Etienne‐Arthur Louis Fallot and his tetralogy
Loukas, Marios , Cesmebasi, Alper , Le, Duong, Etienne, Denzil , Tubbs, R. Shane , Anderson, Robert Henry

Clinical Anatomy | July 17, 2014 | Volume: 27 | Issue: 7 | Pages: 958-963

10.1002/ca.22441 | PMID 25041967 Get It

Étienne‐Arthur Louis Fallot (1850–1911) is one of the most significant medical figures of the 19th century with an eponymous congenital cardiac malformation. His initial account of the four anatomical features making up his tetralogy proved remarkably significant in the progression of clinical descriptions of the lesions producing cyanotic congenital cardiac disease. Although subsequently the cause of appreciable controversy, the accuracy of his initial descriptions underscore the current diagnostic and therapeutic approach to the malformation now known uniformly as tetralogy of Fallot. Clin. Anat. 27:958–963, 2014. © 2014 Wiley Periodicals, Inc.
Dixon‐type and subtraction‐type contrast‐enhanced magnetic resonance angiography: A theoretical and experimental comparison of SNR and CNR
Stinson, Eric G. , Trzasko, Joshua D. , Weavers, Paul T., Riederer, Stephen J.

Magnetic Resonance in Medicine | July 17, 2014 | Volume: 74 | Issue: 1 | Pages: 81-92

10.1002/mrm.25374 | PMID 25043453 Get It

PurposeThe purpose of this work is to compare the behavior of the signal‐to‐noise ratio (SNR) and contrast‐to‐noise ratio (CNR) in contrast‐enhanced MR angiography with background suppression performed by either a Dixon‐type or subtraction‐type method.Theory and MethodsTheoretical expressions for the SNR and CNR for both background suppression techniques were derived. The theoretical Dixon:subtraction SNR and CNR ratios were compared to empirical ratios measured from phantom and in vivo studies for Dixon techniques utilizing one, two, and three echoes. Specifically, the SNR and CNR ratios were compared as the concentration of contrast material in the blood changed.ResultsEmpirical measurements of the SNR and CNR ratios compared favorably with the ratios predicted by theory. As the contrast concentration was reduced, the SNR advantage of the Dixon techniques increased asymptotically. In the ideal case, the SNR improvement over subtraction contrast‐enhanced MR angiography was at least twofold for one‐ and two‐echo Dixon techniques and at least a factor of for the three‐echo Dixon technique.ConclusionExpressions showing a contrast concentration‐dependent SNR and CNR improvement of at least a factor of two when Dixon‐type contrast‐enhanced MR angiography is used in place of subtraction‐type contrast‐enhanced MR angiography were derived and validated with phantom and in vivo experiments. Magn Reson Med 74:81–92, 2015. © 2014 Wiley Periodicals, Inc.
The clinical anatomy of the inferior vena cava: A review of common congenital anomalies and considerations for clinicians
Spentzouris, Georgios , Zandian, Anthony, Cesmebasi, Alper , Kinsella, Christopher R., Muhleman, Mitchel , Mirzayan, Nadine, Shirak, Michelle, Tubbs, R. Shane , Loukas, Marios , Shaffer, Kitt

Clinical Anatomy | July 17, 2014 | Volume: 27 | Issue: 8 | Pages: 1234-1243

10.1002/ca.22445 | PMID 25042045 Get It

Anomalies in the course and drainage of the Inferior Vena Cava (IVC) may complicate normal functioning, correct diagnosis, and therapeutic interventions within the abdomen. Development of the IVC occurs during the 4th to 8th week of gestation, and due to its developmental complexity, there are many opportunities for malformations to occur. Although most IVC anomalies are clinically silent and are usually discovered incidentally on abdominal imaging, aberrations may be responsible for formation of thrombosis, back pain, and anomalous circulation of blood to the heart. In this review, we will discuss the most common variations and abnormalities of the IVC, which include the posterior cardinal veins, the subcardinal veins, the supracardinal veins, persistent left IVC, IVC duplication, situs inversus, left retroaortic renal vein, left circumaortic renal collar, scimitar syndrome, and IVC agenesis. For each abnormality outlined above, we aim to discuss relevant embryology and potential clinical significance with regards to presentation, diagnosis, and treatment as is important for radiologists, surgeons, and clinicians in current clinical practice. Clin. Anat. 27:1234–1243, 2014. © 2014 Wiley Periodicals, Inc.